Search results for "Carcinoma in Situ"

showing 10 items of 48 documents

Innervated Island Flaps in Morphofunctional Vulvar Reconstruction

2000

In this article, the authors present their own experience in vulvar reconstruction following vulvectomy using two different innervated island flaps according to the size and site of the defect. Island-flap mobilization is possible thanks to the rich blood supply of the perineal region. The methods described are a "V-Y amplified sliding flap from the pubis" and a "fasciocutaneous island flap" raised from one or both gluteal folds. The V-Y amplified sliding flap from the pubis is indicated when the defect is symmetric and located anteriorly. This flap is harvested from the pubis and vascularized by the deep arterial network of the pubis. Sensory innervation is provided by branches of the ileo…

AdultReoperationMicrosurgeryReconstructive surgerymedicine.medical_specialtymedicine.medical_treatmentPudendal nerveIsland FlapsSurgical FlapsVulvamedicineHumansAgedNeoplasm StagingWound HealingVulvar NeoplasmsVulvectomybusiness.industrySuture TechniquesAnatomyMiddle AgedMicrosurgerySurgeryPlastic surgerymedicine.anatomical_structureRadical VulvectomyCarcinoma Squamous CellFemaleSurgeryNeoplasm Recurrence LocalbusinessPrecancerous ConditionsCarcinoma in SituPlastic and Reconstructive Surgery
researchProduct

Ultrasound-Guided Breast-Conservative Surgery Decreases the Rate of Reoperations for Palpable Breast Cancer

2018

The purpose of this study is to verify whether the performance of ultrasound-guided quadrantectomy (USGQ) versus palpation-guided quadrantectomy (PGQ) can reduce the incidence of positive margins and if it can change the attitude of the surgeon. A retrospective study was conducted on 842 patients underwent quadrantectomy for breast cancer, 332 of them underwent USGQ, whereas 550 underwent PGQ. The histological type of the tumors and the margin status obtained with the histological examination were compared. The histological examination of the surgical specimen showed involvement of the margins in 24/842 patients (2.85%), 22 (2.61%) of them belonged to the PGQ group, and two to the USGQ gro…

AdultReoperationmedicine.medical_specialtyBreast NeoplasmsMastectomy Segmental03 medical and health sciences0302 clinical medicineBreast cancermedicineHumans030212 general & internal medicineAgedRetrospective StudiesAged 80 and overPalpationbusiness.industryCarcinoma in situIncidence (epidemiology)Gold standardCarcinomaMargins of ExcisionRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseUltrasound guidedBreast conservative surgeryTreatment Outcome030220 oncology & carcinogenesisFemaleSurgeryRadiologyUltrasonography MammarybusinessQuadrantectomy
researchProduct

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.

2003

Timely diagnosis of intraepithelial neoplasias (IN) and colitis-associated colon carcinomas (CRC) is crucially important for the treatment of ulcerative colitis (UC). We performed a randomized, controlled trial to test whether chromoendoscopy (CE) might facilitate early detection of IN and CRC in UC.A total of 263 patients with long-standing UC (or=8 years) were screened for potential inclusion in the study, 165 of whom were randomized at a 1:1 ratio to undergo conventional colonoscopy or colonoscopy with CE using 0.1% methylene blue. Five mucosal biopsy specimens were taken every 10 cm between the rectum and cecum. Circumscript lesions in the colon were evaluated according to a modified pi…

Adultmedicine.medical_specialtyColorectal cancerBiopsyRectumColonoscopyPilot ProjectsGastroenterologySeverity of Illness IndexChromoendoscopyPredictive Value of TestsInternal medicineBiopsymedicineHumansProspective StudiesColitisColoring AgentsAgedIntraepithelial neoplasiaHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyMiddle Agedmedicine.diseaseUlcerative colitisMethylene Bluemedicine.anatomical_structureColonic NeoplasmsColitis UlcerativebusinessCarcinoma in SituGastroenterology
researchProduct

Prevalence of human papillomavirus types in women screened by cytology in Germany.

2007

Incidence and mortality rates of cervical cancer are higher in Germany than in other Western European countries. Type-specific human papillomavirus (HPV) distribution was investigated for the first time in Germany in an epidemiological study including 8,101 women. Women above the age of 30 years, self-referring for cervical cancer screening, were enrolled in two study centers in Hannover (Northern Germany) and Tubingen (Southern Germany). Participants were screened by the Pap smear and the hybrid capture 2 (HC2) test using the high-risk probe. All samples that were positive by the HC2 test were genotyped using the prototype PGMY09/11 PCR line blot assay. Most women in the study population h…

Adultmedicine.medical_specialtyCytodiagnosisUterine Cervical NeoplasmsCervical intraepithelial neoplasiaCohort StudiesSpecies SpecificityRisk FactorsVirologyGermanyEpidemiologymedicinePrevalenceHumansPapillomaviridaePapillomaviridaeGynecologyCervical cancerbiologybusiness.industryObstetricsMortality rateIncidence (epidemiology)Papillomavirus InfectionsMiddle Agedbiology.organism_classificationmedicine.diseaseVirologyVaccinationInfectious DiseasesPopulation studyFemalebusinessCarcinoma in SituJournal of medical virology
researchProduct

Chromoscopy-Guided Endomicroscopy Increases the Diagnostic Yield of Intraepithelial Neoplasia in Ulcerative Colitis

2007

Background & Aims: Because of the large number of biopsy specimens, surveillance colonoscopy in ulcerative colitis (UC) is currently time consuming and significant flat lesions still may be missed. In this study we assessed the value of combined chromoscopy and endomicroscopy for the diagnosis of intraepithelial neoplasias in a randomized controlled trial. Methods: A total of 161 patients with long-term UC in clinical remission were randomized at a 1:1 ratio to undergo conventional colonoscopy or chromoscopy with endomicroscopy. Eight patients were excluded because of insufficient bowel preparation. In the conventional colonoscopic group (n = 73), random biopsy examinations and targeted bio…

Adultmedicine.medical_specialtyTime FactorsColonBiopsyVideo RecordingSensitivity and SpecificitySeverity of Illness IndexTargeted biopsyGastroenterologyChromoendoscopyPredictive Value of TestsInternal medicineBiopsyEndomicroscopyHumansMedicineIntestinal MucosaColitisColoring AgentsAgedFluorescent DyesIntraepithelial neoplasiaMicroscopy ConfocalHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyMiddle Agedmedicine.diseaseUlcerative colitisMethylene BluePredictive value of testsColonic NeoplasmsColitis UlcerativeFluoresceinRadiologybusinessCarcinoma in SituGastroenterology
researchProduct

Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade…

2018

The aim of this multi-institutional study was to identify predictors of residual high-grade (HG) disease at re-transurethral resection (reTUR) in a large cohort of primary T1 HG/Grade 3 (G3) bladder cancer patients. A total of 1155 patients with primary T1 HG/G3 bladder cancer from 13 academic institutions that underwent a reTUR within 6 weeks after first TUR were evaluated. Logistic regression analysis was performed to assess the association of predictive factors with residual HG at reTUR. Residual HG cancer was found in 288 (24.9%) of patients at reTUR. Patients presenting residual HG cancer were more likely to have carcinoma in situ (CIS) at first resection (p=25 kg/m2. On multivariable …

Bladder cancer; High-grade; Neutrophil-to-lymphocytes ratio; Re-transurethral resection; Oncologymedicine.medical_specialty030232 urology & nephrologyUrologyOverweightResidualLogistic regressionSettore MED/24 - Urologia03 medical and health sciences0302 clinical medicineRe-transurethral resectionHigh-grademedicinehigh-grade2. Zero hungerBladder cancerScience & Technologybusiness.industryCarcinoma in situBladder cancerCancerre-transurethral resectionmedicine.disease3. Good healthre-transurethral resection.Oncology030220 oncology & carcinogenesisConcomitantCohortbladder cancermedicine.symptomNeutrophil-to-lymphocytes ratiobusinessneutrophil-to-lymphocytes ratioResearch Paper
researchProduct

Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia.

2007

Background and study aims Endoscopic resection of esophageal squamous-cell neoplasia with curative intent is considered to be a safe and effective alternative treatment to radical surgery in cases where the neoplasia is intraepithelial or limited to the mucosal layer. These patients are at risk for recurrent malignancy in the preserved esophagus, however. We conducted a prospective study to evaluate the efficacy and safety of endoscopic resection and to analyze variables associated with recurrence in patients with mucosal or intraepithelial squamous-cell neoplasia. Patients and methods Between December 1997 and September 2005, 65 patients (mean age +/- standard deviation [SD] 62.9 +/- 9.5 y…

Endoscopic ultrasoundMalemedicine.medical_specialtyEsophageal NeoplasmsmedicineCarcinomaHumansProspective StudiesEsophagusRadical surgerySurvival rateAgedNeoplasm StagingIntraepithelial neoplasiamedicine.diagnostic_testEsophageal diseasebusiness.industryGastroenterologyMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureHigh Grade Intraepithelial NeoplasiaFemaleEsophagoscopybusinessCarcinoma in SituEndoscopy
researchProduct

TERT promoter mutation subtypes in 20 in-situ melanomas

2019

In situCancer ResearchSkin NeoplasmsDermatologyBiologyPrognosisMolecular biologyOncologyMutationBiomarkers TumorHumansTert promoter mutationPromoter Regions GeneticMelanomaTelomeraseCarcinoma in SituMelanoma Research
researchProduct

Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.

1999

The histological distinction between ductal hyperplasia of the breast, atypical ductal hyperplasia and ductal carcinoma in situ is difficult and subjective. To gain a better understanding of these lesions, we performed a comparative study comprising 20 cases of ductal hyperplasia without atypia, 20 cases of ductal hyperplasia with atypia, and 30 cases of ductal carcinoma in situ (well-, moderately- and poorly-differentiated), using quantitative techniques: image cytometry analysis, morphometry and DNA analysis, and DNA flow cytometry. Our results confirm that the mean nuclear area and volume progressively decreased from ductal carcinoma in situ to ductal hyperplasia without atypia. The diff…

In situPathologymedicine.medical_specialtyBreast NeoplasmsCell SeparationPathology and Forensic MedicineFlow cytometryAtypiaImage Processing Computer-AssistedMedicineHumansDuctal Hyperplasiaskin and connective tissue diseasesneoplasmsDNA Image CytometryImage CytometryCell NucleusPloidiesintegumentary systemmedicine.diagnostic_testbusiness.industryCarcinoma Ductal BreastCell BiologyDNA NeoplasmDuctal carcinomaHyperplasiamedicine.diseaseFlow Cytometrybody regionsImage CytometryFemalebusinessPrecancerous ConditionsCarcinoma in SituPathology, research and practice
researchProduct

Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading?

2017

We have previously provided molecular evidence of expression of aquaporin 3 (AQP3) in normal human urothelium and in UBC of various stages. Whereas former studies demonstrated that loss of AQP3 was associated with invasive and high-grade disease and worse progression-free and cancer-specific survival, this report investigates the expression of AQP3 in associated CIS. Contrary to what we had expected, all CIS specimens were shown to exhibit strong AQP3 expression, suggesting loss of AQP3 in UBC is primarily associated with the ability of tumor cells for invasion but not with grading as sign of dedifferentiation.

Invasion depthPathologymedicine.medical_specialtyUrologyCarcinoma in situShort CommunicationBladder030232 urology & nephrologycarcinoma in situMolecular evidenceBiologymedicine.disease03 medical and health sciences0302 clinical medicineOncologyAquaporin 3030220 oncology & carcinogenesisimmunohistochemistrymedicineImmunohistochemistryUrotheliumaquaporin 3Grading (tumors)urothelial carcinomaUrothelial carcinomaBladder Cancer (Amsterdam, Netherlands)
researchProduct